Evidence mapPaperPMID 33387341Full record

SynthesisJournal of nephrology2021

Efficacy of aerobic exercise on the cardiometabolic and renal outcomes in patients with chronic kidney disease: a systematic review of randomized controlled trials.

Ryohei Yamamoto, Takafumi Ito, Yasuyuki Nagasawa, Kosuke Matsui, Masahiro Egawa, Masayoshi Nanami, Yoshitaka Isaka, Hirokazu Okada

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ryohei YamamotoHealth and Counseling Center, Osaka University, 1-17 Machikaneyama-cho, Toyonaka, Osaka, 560-0043, Japan. yamamoto@hacc.osaka-u.ac.jp.ORCID 0000-0003-2610-9824
Takafumi ItoDivision of Nephrology, Faculty of Medicine, Shimane University, Izumo, Japan.ORCID 0000-0003-0677-6566
Yasuyuki NagasawaDepartment of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Kosuke MatsuiDepartment of Nephrology, Izumo Citizens Hospital, Izumo, Japan.
Masahiro EgawaDivision of Nephrology, Faculty of Medicine, Shimane University, Izumo, Japan.
Masayoshi NanamiDepartment of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Yoshitaka IsakaDepartment of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Hirokazu OkadaDepartment of Nephrology, Saitama Medical University, Iruma-gun, Saitama, Japan.ORCID 0000-0002-1839-9078
Hyogo Medical University · JPShimane University · JPThe University of Osaka · JPSaitama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral randomized controlled trials (RCTs) have demonstrated the cardiometabolic effects of aerobic exercise in the general population and in patients with cardiovascular diseases. However, the efficacy of aerobic exercise in patients with chronic kidney disease (CKD) remains to be elucidated.

methodsRCTs comparing aerobic exercise with no aerobic exercise in patients with CKD not requiring kidney replacement therapy were identified through PubMed using RobotAnalyst, a web-based software system that combines text-mining and machine learning algorithms for organizing references. Cardiometabolic and renal outcomes of interest included body mass index (BMI); systolic blood pressure (SBP); hemoglobin A1c (HbA1c), total cholesterol (TCHO), low- and high- density lipoprotein cholesterol (LDLC and HDLC, respectively), and urinary protein (UP) levels/concentration; peak oxygen uptake (Vo

resultsA total of 15 trials, including 622 patients, were included. Their follow-up periods were 3-4, 6-12, and > 12-months in 7 (46.7%), 7 (46.7%), and 1 (6.7%) trial(s), respectively. Meta-analyses showed that aerobic exercise significantly decreased BMI (SMD, -0.19 [95% confidence interval, -0.38, -0.00]) and SBP (-0.75 [-1.24, -0.26]) and increased Vo

conclusionAerobic exercise of 3-12 months' duration improved obesity, high blood pressure, and low exercise capacity in overweight/obese patients with CKD, but it had no significant effect on GFR and proteinuria. Well-designed large RCTs with a longer follow-up period are needed to evaluate the efficacy of aerobic exercise in patients with CKD.

Indexed as

Cardiovascular DiseasesRenal Insufficiency, ChronicExerciseExercise TherapyHumansKidneyRandomized Controlled Trials as TopicAerobic exerciseChronic kidney diseaseMeta-regressionRandomized controlled trialSystematic review

Identifiers

PMID33387341
OpenAlexW3115989896

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.